Sponsored by:

Molecular Imaging: Page 445

Bristol-Myers Squibb finds buyer for imaging unit
By AuntMinnie.com staff writers
Pharmaceutical developer Bristol-Myers Squibb of New York City has inked a deal to sell its medical imaging unit to a private equity firm for $525 million. The deal will include the division's portfolio of contrast products, including its popular Cardiolite radiopharmaceutical for cardiac SPECT imaging.
December 16, 2007
MDS expects less impact from reactor shutdown
By AuntMinnie.com staff writers
MDS, parent company to radioisotope developer MDS Nordion of Kanata, Ontario, said the temporary shutdown of the Chalk River nuclear reactor will have less of a financial impact on the company than anticipated.
December 16, 2007
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
December 16, 2007
Canadian Senate OKs Chalk River restart
By AuntMinnie.com staff writers
The Senate in Canada's Parliament last night approved legislation to restart the Chalk River nuclear reactor, which manufactures radioisotopes for nuclear medicine applications.
December 12, 2007
PET helps predict surgical outcome in refractory epilepsy patients
By Wayne Forrest
A study based at the Cleveland Clinic in Ohio shows surgical outcome in refractory epilepsy can be predicted by PET imaging, even in patients with frequent seizures or spiking activity. The study authors presented their findings at the recent RSNA 2007 meeting in Chicago.
December 12, 2007
MU seeks funds for new molybdenum-99 source
By AuntMinnie.com staff writers
The Missouri University Research Reactor (MURR) Center is hoping to become a U.S. supplier of molybdenum-99 (Mo-99), aiming to reduce reliance on foreign sources for the base isotope for technetium-99m.
December 11, 2007
Cellectar opens new facility
By AuntMinnie.com staff writers
Radiopharmaceutical firm Cellectar has opened a new $3.3 million radiopharmaceutical research, development, and manufacturing facility and headquarters in Madison, WI.
December 11, 2007
Cellectar opens new facility
By AuntMinnie.com staff writers
Radiopharmaceutical firm Cellectar has opened a new $3.3 million radiopharmaceutical research, development, and manufacturing facility and headquarters in Madison, WI.
December 10, 2007
ACR advises on Tc-99m shortage
By AuntMinnie.com staff writers
The Reston, VA-based American College of Radiology (ACR) says "severe cutbacks" are occurring in nuclear cardiology with the loss of more than 50% of the North American molybdenum-99 (Mo-99) supply, due to the prolonged shutdown of the Chalk River nuclear reactor in Ottawa, Canada.
December 10, 2007
AMIC speeds up launch date for technetium generators
By AuntMinnie.com staff writers
Medical isotope developer Advanced Medical Isotope (AMIC) said that it is accelerating the launch of its compact generator systems and technology in response to the extended shutdown of a Canadian reactor producing the base isotope for technetium-99m.
December 10, 2007
Gamma Medica notches sale to Louisiana health center
By AuntMinnie.com staff writers
Gamma camera developer Gamma Medica-Ideas of Northridge, CA, has sold one of its Flex Triumph multimodality preclinical molecular imaging systems to Louisiana State University Health Sciences Center in Shreveport.
December 6, 2007
UM researchers develop 'green' nanoparticles for cancer treatment
By Wayne Forrest
Nanotechnology is going green with the help of some magic beans -- OK, actually they're soybeans. A group of researchers at the University of Missouri-Columbia (UM) has developed a method of using natural ingredients like soybeans to produce gold nanoparticles for the diagnosis and treatment of cancerous tumors.
December 6, 2007
2007 12 06 17 04 00 706
Previous Page
Page 445 of 612
Next Page